These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 25224412)

  • 41. Quantity and Quality Reconstitution of NKG2A
    Hu LJ; Zhao XY; Yu XX; Lv M; Han TT; Han W; Huang XJ
    Biol Blood Marrow Transplant; 2019 Jan; 25(1):1-11. PubMed ID: 30142416
    [TBL] [Abstract][Full Text] [Related]  

  • 42. CD4 Donor Lymphocyte Infusion Can Cause Conversion of Chimerism Without GVHD by Inducing Immune Responses Targeting Minor Histocompatibility Antigens in HLA Class II.
    van Balen P; van Bergen CAM; van Luxemburg-Heijs SAP; de Klerk W; van Egmond EHM; Veld SAJ; Halkes CJM; Zwaginga JJ; Griffioen M; Jedema I; Falkenburg JHF
    Front Immunol; 2018; 9():3016. PubMed ID: 30619360
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Donor CD8+ T cells mediate graft-versus-leukemia activity without clinical signs of graft-versus-host disease in recipients conditioned with anti-CD3 monoclonal antibody.
    Zhang C; Lou J; Li N; Todorov I; Lin CL; Cao YA; Contag CH; Kandeel F; Forman S; Zeng D
    J Immunol; 2007 Jan; 178(2):838-50. PubMed ID: 17202345
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Anti-CD3 preconditioning separates GVL from GVHD via modulating host dendritic cell and donor T-cell migration in recipients conditioned with TBI.
    Li N; Chen Y; He W; Yi T; Zhao D; Zhang C; Lin CL; Todorov I; Kandeel F; Forman S; Zeng D
    Blood; 2009 Jan; 113(4):953-62. PubMed ID: 18922852
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Interleukin-2 inhibits graft-versus-host disease-promoting activity of CD4+ cells while preserving CD4- and CD8-mediated graft-versus-leukemia effects.
    Sykes M; Harty MW; Szot GL; Pearson DA
    Blood; 1994 May; 83(9):2560-9. PubMed ID: 7909457
    [TBL] [Abstract][Full Text] [Related]  

  • 46. How important is NK alloreactivity and KIR in allogeneic transplantation?
    Shaffer BC; Hsu KC
    Best Pract Res Clin Haematol; 2016 Dec; 29(4):351-358. PubMed ID: 27890259
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of FK506 on donor T-cell functions that are responsible for graft-versus-host disease and graft-versus-leukemia effect.
    Imado T; Iwasaki T; Kuroiwa T; Sano H; Hara H
    Transplantation; 2004 Feb; 77(3):391-8. PubMed ID: 14966413
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Graft-versus-host disease is enhanced by selective CD73 blockade in mice.
    Wang L; Fan J; Chen S; Zhang Y; Curiel TJ; Zhang B
    PLoS One; 2013; 8(3):e58397. PubMed ID: 23520507
    [TBL] [Abstract][Full Text] [Related]  

  • 49. During acute graft versus host disease CD28 deletion in donor CD8
    Uri A; Lühder F; Kerkau T; Beyersdorf N
    Eur J Immunol; 2018 Dec; 48(12):2055-2067. PubMed ID: 30320878
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Haploidentical Natural Killer Cells Infused before Allogeneic Stem Cell Transplantation for Myeloid Malignancies: A Phase I Trial.
    Lee DA; Denman CJ; Rondon G; Woodworth G; Chen J; Fisher T; Kaur I; Fernandez-Vina M; Cao K; Ciurea S; Shpall EJ; Champlin RE
    Biol Blood Marrow Transplant; 2016 Jul; 22(7):1290-1298. PubMed ID: 27090958
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The graft-versus-leukemia effect using matched unrelated donors is not superior to HLA-identical siblings for hematopoietic stem cell transplantation.
    Ringdén O; Pavletic SZ; Anasetti C; Barrett AJ; Wang T; Wang D; Antin JH; Di Bartolomeo P; Bolwell BJ; Bredeson C; Cairo MS; Gale RP; Gupta V; Hahn T; Hale GA; Halter J; Jagasia M; Litzow MR; Locatelli F; Marks DI; McCarthy PL; Cowan MJ; Petersdorf EW; Russell JA; Schiller GJ; Schouten H; Spellman S; Verdonck LF; Wingard JR; Horowitz MM; Arora M
    Blood; 2009 Mar; 113(13):3110-8. PubMed ID: 19059878
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Acute GVHD in patients receiving IL-15/4-1BBL activated NK cells following T-cell-depleted stem cell transplantation.
    Shah NN; Baird K; Delbrook CP; Fleisher TA; Kohler ME; Rampertaap S; Lemberg K; Hurley CK; Kleiner DE; Merchant MS; Pittaluga S; Sabatino M; Stroncek DF; Wayne AS; Zhang H; Fry TJ; Mackall CL
    Blood; 2015 Jan; 125(5):784-92. PubMed ID: 25452614
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Preimplantation factor reduces graft-versus-host disease by regulating immune response and lowering oxidative stress (murine model).
    Azar Y; Shainer R; Almogi-Hazan O; Bringer R; Compton SR; Paidas MJ; Barnea ER; Or R
    Biol Blood Marrow Transplant; 2013 Apr; 19(4):519-28. PubMed ID: 23266739
    [TBL] [Abstract][Full Text] [Related]  

  • 54. PD-L1 serves as a double agent in separating GVL from GVHD.
    Brennan TV; Yang Y
    J Clin Invest; 2017 May; 127(5):1627-1630. PubMed ID: 28414300
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Abrogation of donor T-cell IL-21 signaling leads to tissue-specific modulation of immunity and separation of GVHD from GVL.
    Hanash AM; Kappel LW; Yim NL; Nejat RA; Goldberg GL; Smith OM; Rao UK; Dykstra L; Na IK; Holland AM; Dudakov JA; Liu C; Murphy GF; Leonard WJ; Heller G; van den Brink MR
    Blood; 2011 Jul; 118(2):446-55. PubMed ID: 21596854
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Programming of donor T cells using allogeneic δ-like ligand 4-positive dendritic cells to reduce GVHD in mice.
    Mochizuki K; Meng L; Mochizuki I; Tong Q; He S; Liu Y; Purushe J; Fung H; Zaidi MR; Zhang Y; Reshef R; Blazar BR; Yagita H; Mineishi S; Zhang Y
    Blood; 2016 Jun; 127(25):3270-80. PubMed ID: 27143255
    [TBL] [Abstract][Full Text] [Related]  

  • 57. NK cells mediate reduction of GVHD by inhibiting activated, alloreactive T cells while retaining GVT effects.
    Olson JA; Leveson-Gower DB; Gill S; Baker J; Beilhack A; Negrin RS
    Blood; 2010 May; 115(21):4293-301. PubMed ID: 20233969
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Donor APCs are required for maximal GVHD but not for GVL.
    Matte CC; Liu J; Cormier J; Anderson BE; Athanasiadis I; Jain D; McNiff J; Shlomchik WD
    Nat Med; 2004 Sep; 10(9):987-92. PubMed ID: 15286785
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Promoting regulation via the inhibition of DNAM-1 after transplantation.
    Koyama M; Kuns RD; Olver SD; Lineburg KE; Lor M; Teal BE; Raffelt NC; Leveque L; Chan CJ; Robb RJ; Markey KA; Alexander KA; Varelias A; Clouston AD; Smyth MJ; MacDonald KP; Hill GR
    Blood; 2013 Apr; 121(17):3511-20. PubMed ID: 23430112
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Experimental and clinical approaches for optimization of the graft-versus-leukemia effect.
    Sprangers B; Van Wijmeersch B; Fevery S; Waer M; Billiau AD
    Nat Clin Pract Oncol; 2007 Jul; 4(7):404-14. PubMed ID: 17597705
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.